Novocure's IPO

Novocure raised a round of funding on October 02, 2015. Investors include Public.

Novocure is a private oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields. Headquartered in Jersey Isle, Novocure's US operations are based in Portsm…

Articles about Novocure's IPO: